ACUMEN PHARMACEUTICALS INC
ABOSNASDAQ🏆 #3688 by market capEarnings Mar 24 · PostUS Equity
$2.38▲ $0.12 (+5.31%)
Market closed · at closeTrack ABOS
Get earnings, price moves & breaking news on Telegram
24h▲ 5.3%
7d▲ 15.5%
14d▲ 43.4%
30d▲ 6.5%
ytd▲ 14.1%
1y▲ 5.3%
🏦Market Cap
$172M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
113.5x
Expensive
Otter Score
—
Insufficient data
ACUMEN PHARMACEUTICALS INC
ABOSAnalyst Ratings
Price
$2.38
Total
8
Raised
0
Lowered
0
Avg PT
$7.00
H / L
$7 / $7
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BTIG | Reiterated | Buy | 2026-09-16 | — | — |
Citigroup | Reiterated | Buy | 2026-09-15 | $7.00 | +194.10% |
B of A Securities | Reiterated | Buy | 2025-11-18 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-03-28 | — | — |
UBS | Reiterated | Buy | 2025-03-28 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-08-09 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2023-07-17 | — | — |
Stifel | Reiterated | Buy | 2021-07-26 | — | — |
Institution
BTIG
Reiterated · Buy · 2026-09-16
—
—
Citigroup
Reiterated · Buy · 2026-09-15
$7.00
+194.10%
B of A Securities
Reiterated · Buy · 2025-11-18
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-03-28
—
—
UBS
Reiterated · Buy · 2025-03-28
—
—
Credit Suisse
Reiterated · Outperform · 2023-08-09
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2023-07-17
—
—
Stifel
Reiterated · Buy · 2021-07-26
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space